Company Profiles

driven by the PitchBook Platform

Apellis

Description

Developer of novel therapeutics and drug delivery technologies. The company develops peptide drugs focused on the immunology space such as asthma and chronic obstructive pulmonary disease.

2009

Founded

PRIVATE

Status

11-50

Employees

Series D

Latest Deal Type

$47.1M

Latest Deal Amount

$95.5M

Total Amount Raised

Description

Developer of novel therapeutics and drug delivery technologies. The company develops peptide drugs focused on the immunology space such as asthma and chronic obstructive pulmonary disease.

Website:

www.apellis.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Drug Delivery
Biotechnology

Primary Office

6400 Westwind Way Suite A Crestwood, KY 40014United States +1 (502) 241-4114
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Apellis's full profile, request a free trial.

Apellis Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Apellis Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Apellis Investors (11)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
AJU IB InvestmentVenture CapitalMinority000 0000000 0000
Cormorant Asset ManagementHedge FundMinority000 0000000 0000
Epidarex CapitalVenture CapitalMinority000 0000000 0000
HealthCare VenturesVenture CapitalMinority000 0000000 0000
Hillhouse Capital ManagementVenture CapitalMinority000 0000000 0000
AJU IB Investment Venture Capital
Cormorant Asset Management Hedge Fund
Epidarex Capital Venture Capital
HealthCare Ventures Venture Capital
Hillhouse Capital Management Venture Capital

Apellis Executive Team (13)

NameTitleBoard
Seat
Contact
Info
Mike Yeadon Ph.DConsultant (Acting Chief Scientific Officer)
Candace DeppProject Manager & Co-Founder
David Watson JDVice President, Corporate Development & General Counsel
Federico Grossi Ph.DVice President, Clinical Development
Nicole PerryVice President, Finance
Mike Yeadon Ph.D Consultant (Acting Chief Scientific Officer)
Candace Depp Project Manager & Co-Founder
David Watson JD Vice President, Corporate Development & General Counsel
Federico Grossi Ph.D Vice President, Clinical Development
Nicole Perry Vice President, Finance

Apellis Board Members (9)

NameRepresentingRoleSinceContact
Info
Alec MachielsPegasus Capital AdvisorsPartner000 0000
Bihua ChenCormorant Asset ManagementChief Executive Officer & Portfolio Manager000 0000
Cedric Francois Ph.DSelfChief Executive Officer, Board Member, President & Co-Founder000 0000
David DarstSelfBoard Member & Co-Founder000 0000
Gerald Chan Ph.DMorningside GroupCo-Founder & Chairman000 0000
Alec Machiels Partner Pegasus Capital Advisors
Bihua Chen Chief Executive Officer & Portfolio Manager Cormorant Asset Management
Cedric Francois Ph.D Chief Executive Officer, Board Member, President & Co-Founder Self
David Darst Board Member & Co-Founder Self
Gerald Chan Ph.D Co-Founder & Chairman Morningside Group
Request full access to PitchBook